节点文献

抗体细胞因子融合蛋白治疗肿瘤的研究进展

Progress of Antibody-cytokine Fusion Proteins for the Therapy of Cancer

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 顾军王雅杰

【Author】 GU Jun,WANG Ya-jie.Department of Oncology,The 123 Hospital of Chinese PLA,Bengbu 233015,China

【机构】 解放军第123医院肿瘤科上海市长海医院肿瘤科 安徽蚌埠233015上海200433

【摘要】 抗体细胞因子融合蛋白保持了抗体和细胞因子两者的功能 ,能在肿瘤微环境浓集并直接增大抗体的抗肿瘤效应和 或宿主的抗肿瘤免疫。综述了IgG融合IL 2、GM CSF和IL 12融合蛋白的结构、生物学特性和用于治疗人类肿瘤的潜能

【Abstract】 Antibody-cytokine fusion proteins retain both antibody and cytokine associated functions.These moleculars can concentrate the cytokine in the tumor microenvironment and in so doing directly enhance the tumoricidal effect of the antibody and/or enhance the host immune response against the tumor.This paper reviews the construction of several antibody-cytokine fusion proteins with IgG fused to the cytokine such as interleukin-2 (IL-2),granulocyte/macrophage colony-stimulating factor (GM-CSF),and interleukin-12 (IL-12),describes the properties of biology,and discusses the potential use in the treatment of human cancer.

  • 【文献出处】 肿瘤防治杂志 ,Journal of Qilu Oncology , 编辑部邮箱 ,2003年02期
  • 【分类号】R730.5
  • 【被引频次】4
  • 【下载频次】132
节点文献中: 

本文链接的文献网络图示:

本文的引文网络